SPDR S&P Biotech ETF Stock Forecast, Price & News

Wall Street analysts have given SPDR S&P Biotech ETF a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but SPDR S&P Biotech ETF wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

SPDR S&P Biotech ETF's stock was trading at $79.00 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, XBI shares have increased by 58.4% and is now trading at $125.10.
View which stocks have been most impacted by COVID-19.

SPDR S&P Biotech ETF pays an annual dividend of $0.32 per share and currently has a dividend yield of 0.26%.
View SPDR S&P Biotech ETF's dividend history.

Based on aggregate information from My MarketBeat watchlists, some companies that other SPDR S&P Biotech ETF investors own include Intel (INTC), NVIDIA (NVDA), Pfizer (PFE), Gilead Sciences (GILD), iShares Nasdaq Biotechnology ETF (IBB), The Walt Disney (DIS), Micron Technology (MU), Cisco Systems (CSCO), AbbVie (ABBV) and Netflix (NFLX).

SPDR S&P Biotech ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "XBI."

SPDR S&P Biotech ETF's stock is owned by many different retail and institutional investors. Top institutional investors include GSB Wealth Management LLC (2.49%), Bank Julius Baer & Co. Ltd Zurich (0.68%), Whittier Trust Co. (0.47%), Migdal Insurance & Financial Holdings Ltd. (0.45%), Fifth Third Bancorp (0.34%) and Weatherly Asset Management L. P. (0.33%).

XBI stock was sold by a variety of institutional investors in the last quarter, including Strs Ohio, Ilmarinen Mutual Pension Insurance Co, Rockefeller Capital Management L.P., Stevens Capital Management LP, Papp L Roy & Associates, TrinityPoint Wealth LLC, D L Carlson Investment Group Inc., and Landsberg Bennett & Dubbaneh LLC.

XBI stock was acquired by a variety of institutional investors in the last quarter, including GSB Wealth Management LLC, Migdal Insurance & Financial Holdings Ltd., Howard Capital Management Group LLC, Pictet & Cie Europe SA, Bell Bank, Bank Julius Baer & Co. Ltd Zurich, Meitav Dash Investments Ltd., and Engrave Wealth Partners LLC.

Shares of XBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of XBI stock can currently be purchased for approximately $125.10.

SPDR S&P Biotech ETF has a market capitalization of $6.84 billion.

The official website for SPDR S&P Biotech ETF is www.spdrs.com.

SPDR S&P Biotech ETF is headquartered at One Lincoln Street, Boston, 02111, United States.

SPDR S&P Biotech ETF's mailing address is One Lincoln Street, Boston, 02111, United States. The exchange traded fund can be reached via phone at +1-866-7872257.